AMTD IDEA GROUP (AMTD)
AMTD IDEAs Receipt of NYSE Letter Regarding ADS Trading Prices Below Compliance Standards
IM CANNABIS CORP. (IMCC)
IM Cannabis Raises US$250,000 of Gross Proceeds in Convertible Note Financing
CAREDX, INC. (CDNA)
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
INTELLIA THERAPEUTICS, INC. (NTLA)
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NRX PHARMACEUTICALS, INC. (NRXP)
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (KNSA)
Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference
ATYR PHARMA INC (ATYR)
aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD
PETVIVO HOLDINGS INC. (PETV)
PetVivo Sets Fiscal First Quarter 2027 Conference Call for Friday, August 14, 2026 at 5:00 p.m. ET
CIRRUS LOGIC, INC. (CRUS)
Cirrus Logic to Present at Upcoming Conference
ARCUTIS BIOTHERAPEUTICS, INC. (ARQT)
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)